Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Etomoxir Actions on Regulatory and Memory T Cells Are Independent of Cpt1a-Mediated Fatty Acid Oxidation.

Raud B, Roy DG, Divakaruni AS, Tarasenko TN, Franke R, Ma EH, Samborska B, Hsieh WY, Wong AH, Stüve P, Arnold-Schrauf C, Guderian M, Lochner M, Rampertaap S, Romito K, Monsale J, Brönstrup M, Bensinger SJ, Murphy AN, McGuire PJ, Jones RG, Sparwasser T, Berod L.

Cell Metab. 2018 Sep 4;28(3):504-515.e7. doi: 10.1016/j.cmet.2018.06.002. Epub 2018 Jun 28.

PMID:
30043753
2.

Mitochondrial cyclophilin D regulates T cell metabolic responses and disease tolerance to tuberculosis.

Tzelepis F, Blagih J, Khan N, Gillard J, Mendonca L, Roy DG, Ma EH, Joubert P, Jones RG, Divangahi M.

Sci Immunol. 2018 May 11;3(23). pii: eaar4135. doi: 10.1126/sciimmunol.aar4135.

PMID:
29752301
3.

Neoadjuvant oncolytic virotherapy before surgery sensitizes triple-negative breast cancer to immune checkpoint therapy.

Bourgeois-Daigneault MC, Roy DG, Aitken AS, El Sayes N, Martin NT, Varette O, Falls T, St-Germain LE, Pelin A, Lichty BD, Stojdl DF, Ungerechts G, Diallo JS, Bell JC.

Sci Transl Med. 2018 Jan 3;10(422). pii: eaao1641. doi: 10.1126/scitranslmed.aao1641.

PMID:
29298865
4.

Brief Communication; A Heterologous Oncolytic Bacteria-Virus Prime-Boost Approach for Anticancer Vaccination in Mice.

Aitken AS, Roy DG, Martin NT, Sad S, Bell JC, Bourgeois-Daigneault MC.

J Immunother. 2018 Apr;41(3):125-129. doi: 10.1097/CJI.0000000000000208.

5.

Taking a Stab at Cancer; Oncolytic Virus-Mediated Anti-Cancer Vaccination Strategies.

Aitken AS, Roy DG, Bourgeois-Daigneault MC.

Biomedicines. 2017 Jan 4;5(1). pii: E3. doi: 10.3390/biomedicines5010003. Review.

6.

Combination of Paclitaxel and MG1 oncolytic virus as a successful strategy for breast cancer treatment.

Bourgeois-Daigneault MC, St-Germain LE, Roy DG, Pelin A, Aitken AS, Arulanandam R, Falls T, Garcia V, Diallo JS, Bell JC.

Breast Cancer Res. 2016 Aug 8;18(1):83. doi: 10.1186/s13058-016-0744-y.

7.

Oncolytic vesicular stomatitis virus expressing interferon-γ has enhanced therapeutic activity.

Bourgeois-Daigneault MC, Roy DG, Falls T, Twumasi-Boateng K, St-Germain LE, Marguerie M, Garcia V, Selman M, Jennings VA, Pettigrew J, Amos S, Diallo JS, Nelson B, Bell JC.

Mol Ther Oncolytics. 2016 Feb 17;3:16001. doi: 10.1038/mto.2016.1. eCollection 2016.

8.

Murine Tumor Models for Oncolytic Rhabdo-Virotherapy.

Falls T, Roy DG, Bell JC, Bourgeois-Daigneault MC.

ILAR J. 2016;57(1):73-85. doi: 10.1093/ilar/ilv048.

9.

Programmable insect cell carriers for systemic delivery of integrated cancer biotherapy.

Roy DG, Power AT, Bourgeois-Daigneault MC, Falls T, Ferreira L, Stern A, Tanese de Souza C, McCart JA, Stojdl DF, Lichty BD, Atkins H, Auer RC, Bell JC, Le Boeuf F.

J Control Release. 2015 Dec 28;220(Pt A):210-221. doi: 10.1016/j.jconrel.2015.10.030. Epub 2015 Oct 19.

PMID:
26482080
10.

MicroRNAs regulate the immunometabolic response to viral infection in the liver.

Singaravelu R, O'Hara S, Jones DM, Chen R, Taylor NG, Srinivasan P, Quan C, Roy DG, Steenbergen RH, Kumar A, Lyn RK, Özcelik D, Rouleau Y, Nguyen MA, Rayner KJ, Hobman TC, Tyrrell DL, Russell RS, Pezacki JP.

Nat Chem Biol. 2015 Dec;11(12):988-93. doi: 10.1038/nchembio.1940. Epub 2015 Oct 19.

PMID:
26479438
11.

Bacterial-mediated knockdown of tumor resistance to an oncolytic virus enhances therapy.

Cronin M, Le Boeuf F, Murphy C, Roy DG, Falls T, Bell JC, Tangney M.

Mol Ther. 2014 Jun;22(6):1188-1197. doi: 10.1038/mt.2014.23. Epub 2014 Feb 26.

12.

Cell carriers for oncolytic viruses: current challenges and future directions.

Roy DG, Bell JC.

Oncolytic Virother. 2013 Oct 9;2:47-56. doi: 10.2147/OV.S36623. eCollection 2013. Review.

13.

Role of omega-3 ethyl ester concentrate in reducing sudden cardiac death following myocardial infarction and in management of hypertriglyceridemia: an Indian consensus statement.

Dalal JJ, Kasliwal RR, Dutta AL, Sawhney JP, Iyengar SS, Dani S, Desai N, Sathyamurthy I, Rao D, Menon A, Dasbiswas A, Wander GS, Chadha M, Hiremath MS, Roy DG, Gupta V, Shivakadaksham N.

Indian Heart J. 2012 Sep-Oct;64(5):503-7. doi: 10.1016/j.ihj.2012.08.004. Epub 2012 Aug 27.

14.

Targeting tumor vasculature with an oncolytic virus.

Breitbach CJ, De Silva NS, Falls TJ, Aladl U, Evgin L, Paterson J, Sun YY, Roy DG, Rintoul JL, Daneshmand M, Parato K, Stanford MM, Lichty BD, Fenster A, Kirn D, Atkins H, Bell JC.

Mol Ther. 2011 May;19(5):886-94. doi: 10.1038/mt.2011.26. Epub 2011 Mar 1.

15.

Generalized optical theorem for scattering in inhomogeneous media.

Dacol DK, Roy DG.

Phys Rev E Stat Nonlin Soft Matter Phys. 2005 Sep;72(3 Pt 2):036609. Epub 2005 Sep 14.

PMID:
16241594
16.

Study of sudden cardiac deaths in young athletes.

Kahali B, Roy DG, Batabyal S, Bose TK.

J Indian Med Assoc. 2002 Dec;100(12):708-9.

PMID:
12793636
17.
18.

Effect of isosorbide dinitrate on non-cirrhotic portal hypertension.

Roy DG, Kaur U, Chawla YK, Singh K, Dilawari JB.

Natl Med J India. 1991 Jan-Feb;4(1):5-9.

PMID:
29751471
19.

Tomosynthesis applied to digital subtraction angiography.

Kruger RA, Sedaghati M, Roy DG, Liu P, Nelson JA, Kubal W, Del Rio P.

Radiology. 1984 Sep;152(3):805-8.

PMID:
6379747

Supplemental Content

Support Center